CVS Balks At Certain Managed Care Promotions Of OTC Switches
This article was originally published in The Tan Sheet
Executive Summary
Rising concerns about the influence that managed care providers are having on the purchase of OTC switch drugs have prompted CVS to voice its opinion in recent letters to the organizations
You may also be interested in...
Aetna Follows Claritin Model, Will Provide Prilosec OTC Coupons
Aetna will join Wellpoint in giving Prilosec OTC a boost by providing coupons worth a free 14-day trial of the product, the insurer announced October 7
J&J/Merck Challenge Prilosec OTC Claims; Insurer Incentives Support Launch
Johnson & Johnson/Merck is contesting claims made in a television spot for P&G's Prilosec OTC that one pill can provide relief for 24 hours
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC